The Importance of Measurement for Quality Improvement : Submaximal Cardiac Stress Testing
© 2020 by the Society of Nuclear Medicine and Molecular Imaging..
One of the most effective techniques to improve quality is to measure quality. The aim of this article is to defend the importance of quality measurement in nuclear medicine using the long-standing problem of submaximal exercise stress testing. Numerous evidence-based guidelines and research studies establish the importance of maximal stress testing for myocardial perfusion imaging. The 3 cutoffs for adequate cardiac stress that must be met are expenditure of 5 metabolic equivalents of energy, production of symptoms (e.g., fatigue or shortness of breath), and attainment of 85% of the maximum predicted heart rate. Measurement and evaluation of these 3 criteria along with several other metrics can help to validate one aspect of laboratory quality related to myocardial perfusion imaging accuracy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Journal of nuclear medicine technology - 48(2020), 2 vom: 12. Juni, Seite 122-125 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Farrell, Mary Beth [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Exercise stress testing |
|---|
| Anmerkungen: |
Date Completed 08.02.2021 Date Revised 08.02.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2967/jnmt.120.244525 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM308621832 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM308621832 | ||
| 003 | DE-627 | ||
| 005 | 20231225132123.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2967/jnmt.120.244525 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1028.xml |
| 035 | |a (DE-627)NLM308621832 | ||
| 035 | |a (NLM)32277062 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Farrell, Mary Beth |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Importance of Measurement for Quality Improvement |b Submaximal Cardiac Stress Testing |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.02.2021 | ||
| 500 | |a Date Revised 08.02.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 by the Society of Nuclear Medicine and Molecular Imaging. | ||
| 520 | |a One of the most effective techniques to improve quality is to measure quality. The aim of this article is to defend the importance of quality measurement in nuclear medicine using the long-standing problem of submaximal exercise stress testing. Numerous evidence-based guidelines and research studies establish the importance of maximal stress testing for myocardial perfusion imaging. The 3 cutoffs for adequate cardiac stress that must be met are expenditure of 5 metabolic equivalents of energy, production of symptoms (e.g., fatigue or shortness of breath), and attainment of 85% of the maximum predicted heart rate. Measurement and evaluation of these 3 criteria along with several other metrics can help to validate one aspect of laboratory quality related to myocardial perfusion imaging accuracy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a exercise stress testing | |
| 650 | 4 | |a guideline adherence | |
| 650 | 4 | |a measurement | |
| 650 | 4 | |a quality improvement | |
| 650 | 4 | |a submaximal stress | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of nuclear medicine technology |d 1997 |g 48(2020), 2 vom: 12. Juni, Seite 122-125 |w (DE-627)NLM091937876 |x 0091-4916 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2020 |g number:2 |g day:12 |g month:06 |g pages:122-125 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2967/jnmt.120.244525 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2020 |e 2 |b 12 |c 06 |h 122-125 | ||